Defining re-implementation.
Moyal-Smith R, Etheridge JC, Karlage A, Sonnay Y, Yuan CT, Havens JM, Brindle ME, Berry W.
Implement Sci Commun. 2023 Jun 05. 4(1):60. PMID: 37277862
Research Scientists
William Robert Berry
Links
Bibliography
Pembrolizumab Plus Docetaxel and Prednisone in Patients with Metastatic Castration-resistant Prostate Cancer: Long-term Results from the Phase 1b/2 KEYNOTE-365 Cohort B Study.
Yu EY, Kolinsky MP, Berry WR, Retz M, Mourey L, Piulats JM, Appleman LJ, Romano E, Gravis G, Gurney H, Bögemann M, Emmenegger U, Joshua AM, Linch M, Sridhar S, Conter HJ, Laguerre B, Massard C, Li XT, Schloss C, Poehlein CH, de Bono JS.
Eur Urol. 2022 07. 82(1):22-30. PMID: 35397952
Improving communication and teamwork during labor: A feasibility, acceptability, and safety study.
Weiseth A, Plough A, Aggarwal R, Galvin G, Rucker A, Henrich N, Miller K, Subramanian L, Hawrusik R, Berry W, Gullo S, Spigel L, Dever K, Loveless D, Graham K, Paek B, Shah NT.
Birth. 2022 12. 49(4):637-647. PMID: 35233810
Examining health care champions: a mixed-methods study exploring self and peer perspectives of champions.
George ER, Sabin LL, Elliott PA, Wolff JA, Osani MC, McSwiggan Hong J, Berry WR.
Implement Res Pract. 2022 Jan-Dec. 3:26334895221077880. PMID: 37091082
Targeted Transcriptome and KRAS Mutation Analysis Improve the Diagnostic Performance of EUS-FNA Biopsies in Pancreatic Cancer.
Lundy J, Gao H, Berry W, Masoumi-Moghoddam S, Jenkins BJ, Croagh D.
Clin Cancer Res. 2021 11 01. 27(21):5900-5911. PMID: 34400416
The design of "TeamBirth": A care process to improve communication and teamwork during labor.
Aggarwal R, Plough A, Henrich N, Galvin G, Rucker A, Barnes C, Berry W, Golen T, Shah NT.
Birth. 2021 12. 48(4):534-540. PMID: 34245054
A prospective trial of abiraterone acetate plus prednisone in Black and White men with metastatic castrate-resistant prostate cancer.
George DJ, Halabi S, Heath EI, Sartor AO, Sonpavde GP, Das D, Bitting RL, Berry W, Healy P, Anand M, Winters C, Riggan C, Kephart J, Wilder R, Shobe K, Rasmussen J, Milowsky MI, Fleming MT, Bearden J, Goodman M, Zhang T, Harrison MR, McNamara M, Zhang D, LaCroix BL, Kittles RA, Patierno BM, Sibley AB, Patierno SR, Owzar K, Hyslop T, Freedman JA, Armstrong AJ.
Cancer. 2021 08 15. 127(16):2954-2965. PMID: 33951180
Circulating Tumor Cell Chromosomal Instability and Neuroendocrine Phenotype by Immunomorphology and Poor Outcomes in Men with mCRPC Treated with Abiraterone or Enzalutamide.
Brown LC, Halabi S, Schonhoft JD, Yang Q, Luo J, Nanus DM, Giannakakou P, Szmulewitz RZ, Danila DC, Barnett ES, Carbone EA, Zhao JL, Healy P, Anand M, Gill A, Jendrisak A, Berry WR, Gupta S, Gregory SG, Wenstrup R, Antonarakis ES, George DJ, Scher HI, Armstrong AJ.
Clin Cancer Res. 2021 07 15. 27(14):4077-4088. PMID: 33820782
Combination of Radiation Therapy and Short-Term Androgen Blockade With Abiraterone Acetate Plus Prednisone for Men With High- and Intermediate-Risk Localized Prostate Cancer.
Koontz BF, Hoffman KE, Halabi S, Healy P, Anand M, George DJ, Harrison MR, Zhang T, Berry WR, Corn PG, Lee WR, Armstrong AJ.
Int J Radiat Oncol Biol Phys. 2021 04 01. 109(5):1271-1278. PMID: 33259932
Prospective Multicenter Study of Circulating Tumor Cell AR-V7 and Taxane Versus Hormonal Treatment Outcomes in Metastatic Castration-Resistant Prostate Cancer.
Armstrong AJ, Luo J, Nanus DM, Giannakakou P, Szmulewitz RZ, Danila DC, Healy P, Anand M, Berry WR, Zhang T, Harrison MR, Lu C, Chen Y, Galletti G, Schonhoft JD, Scher HI, Wenstrup R, Tagawa ST, Antonarakis ES, George DJ, Halabi S.
JCO Precis Oncol. 2020. 4. PMID: 33154984